Home / Stocks / ALB

Albemarle (ALB, Specialty Chemicals) Stock Valuation & Fair Value Fairly valued

Albemarle (ALB, Specialty Chemicals) trades at a blended P/E of 19.3, about 14% above its historical normal valuation, with a forward growth estimate of 21.3% and a PEG of 0.90. Analysts' one-year estimates have been hit 27% of the time.

DATA AS OF 2026-08-21
Blended P/E
19.3
Normal P/E
16.9
PEG
0.90
Fwd growth
21.3%
Div yield
1.2%
RSI (14)
58.3
Neutral

The Street vs SeerForecast

Wall Street's mean price target for ALB is $173.56 across 20 analysts, 21.2% above the current price. The average analyst rating is Buy. Our SeerForecast read of the same stock, formed without analyst targets: fairly valued. When the two disagree, start your digging there.

Valuation flags

Verdict history

tickerseer's rating moved from significantly overvalued (2026-06-03) to fairly valued (2026-08-21).

Price and rating by weekClose moved -18.9 percent from 2026-06-03 to 2026-08-17, with 2 rating changes over 21 recorded weeks.2026-06-03: Significantly overvalued, close 167.91 (recalculated)2026-06-10: Significantly overvalued, close 146.85 (recalculated)2026-06-14: Significantly overvalued, close 170.42 (recalculated)2026-06-16: Significantly overvalued, close 166.11 (recalculated)2026-06-21: Significantly overvalued, close 160.35 (recalculated)2026-07-02: Trading above fair value, close 135.56 (recalculated)2026-07-06: Trading above fair value, close 133.80 (recalculated)2026-07-09: Trading above fair value, close 128.42 (recalculated)2026-07-12: Fairly valued, close 126.05 (recalculated)2026-07-13: Fairly valued, close 125.79 (recalculated)2026-07-14: Fairly valued, close 128.75 (recalculated)2026-07-20: Fairly valued, close 118.20 (recalculated)2026-07-22: Fairly valued, close 117.45 (recalculated)2026-07-25: Fairly valued, close 114.85 (recalculated)2026-07-27: Fairly valued, close 116.18 (recalculated)2026-07-31: Fairly valued, close 117.64 (recalculated)2026-08-03: Fairly valued, close 117.642026-08-07: Fairly valued, close 131.11 (recalculated)2026-08-10: Fairly valued, close 131.112026-08-14: Fairly valued, close 136.15 (recalculated)2026-08-17: Fairly valued, close 136.151681362026-06-032026-08-17
Attractively valuedFairly valuedAbove fair valueLarger dot: a stronger reading

Not every point was recorded live. Points marked recalculated apply today's valuation rules to the metrics tickerseer archived that week.

2026-06-03P/E 40.7+141%Significantly overvalued
2026-06-10P/E 33.2+97%Significantly overvalued
2026-06-14P/E 33.2+97%Significantly overvalued
2026-06-16P/E 33.2+97%Significantly overvalued
2026-06-21P/E 33.2+97%Significantly overvalued
2026-07-02P/E 23.4+39%Trading above fair value
2026-07-06P/E 22.6+34%Trading above fair value
2026-07-09P/E 22.6+34%Trading above fair value
2026-07-12P/E 20.0+19%Fairly valued
2026-07-13P/E 20.0+19%Fairly valued
2026-07-14P/E 20.0+19%Fairly valued
2026-07-20P/E 19.4+15%Fairly valued
2026-07-22P/E 19.4+15%Fairly valued
2026-07-25P/E 17.8+5%Fairly valued
2026-07-27P/E 17.8+5%Fairly valued
2026-07-31P/E 17.6+5%Fairly valued
2026-08-03P/E 17.5+4%Fairly valued
2026-08-07P/E 18.3+9%Fairly valued
2026-08-10P/E 19.1+13%Fairly valued
2026-08-14P/E 19.4+15%Fairly valued
2026-08-17P/E 20.1+20%Fairly valued
2026-08-21P/E 19.3+14%Fairly valued ← now

Frequently asked questions

Is Albemarle stock overvalued?

At a blended P/E of 19.3 versus its historical normal P/E of 16.9, Albemarle trades about 14% above its typical valuation, with a PEG of 0.90 on 21.3% forward growth. tickerseer currently rates it fairly valued.

What is Albemarle's fair value and PEG?

Albemarle trades at a blended P/E of 19.3 against a historical normal P/E of 16.9, a PEG of 0.90, and a forward growth estimate of 21.3%.

Has tickerseer's rating of Albemarle changed?

tickerseer's rating moved from significantly overvalued (2026-06-03) to fairly valued (2026-08-21).

What is the analyst price target for Albemarle?

The mean Wall Street price target for Albemarle is $173.56 across 20 analysts, 21.2% above the current price. tickerseer's SeerForecast verdict is formed independently of analyst targets.

Industry: Specialty Chemicals. Create a free account to see the full analysis: the SeerAI score, its five quality sub-scores, valuation history, and the AI research note. Options setups and metric history are part of the paid plans.

See the full analysis →🔔 Track ALB free: valuation & earnings alerts

Get the free weekly earnings preview

One email each Monday with the week's named earnings setups, the reasoning, and what settled last week. Strikes and sizing stay in Premium.

It's free, and you can unsubscribe any time. Educational content, not investment advice.